UBS Group’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $10.8M | Sell |
|
|||||
|
2025
Q2 | $17.1M | Sell |
|
|||||
|
2025
Q1 | $26.6M | Buy |
|
|||||
|
2024
Q4 | $9.85M | Buy |
|
|||||
|
2024
Q3 | $5.66M | Buy |
|
|||||
|
2024
Q2 | $5.94M | Sell |
|
|||||
|
2024
Q1 | $10.8M | Buy |
|
|||||
|
2023
Q4 | $6.27M | Buy |
|
|||||
|
2023
Q3 | $583K | Buy |
|
|||||
|
2023
Q2 | $26.4K | Sell |
|
|||||
|
2023
Q1 | $2.19M | Sell |
|
|||||
|
2022
Q4 | $5.31M | Buy |
|
|||||
|
2022
Q3 | $1.04M | Sell |
|
|||||
|
2022
Q2 | $2M | Sell |
|
|||||
|
2022
Q1 | $5.48M | Buy |
|
|||||
|
2021
Q4 | $5.05M | Buy |
|
|||||
|
2021
Q3 | $2.56M | Buy |
|
|||||
|
2021
Q2 | $679K | Sell |
|
|||||
|
2021
Q1 | $1.13M | Buy |
|
|||||
|
2020
Q4 | $48K | Buy |
|
|||||
|
2020
Q3 | $23K | Buy |
|
|||||
|
2020
Q2 | $7K | Sell |
|
|||||
|
2020
Q1 | $1K | Sell |
|
|||||
|
2019
Q4 | $3K | Sell |
|
|||||
|
2019
Q3 | $10K | Buy |
|
|||||
|
2019
Q2 | $10K | Buy |
|
|||||
|
2019
Q1 | $1K | Sell |
|
|||||
|
2018
Q4 | $14K | Buy |
|
|||||
|
2018
Q3 | $1K | Sell |
|
|||||
|
2018
Q2 | $33K | Buy |
|
|||||
|
2018
Q1 | $81K | Sell |
|
|||||
|
2017
Q4 | $100K | Sell |
|
|||||
|
2017
Q3 | $219K | Buy |
|
|||||
|
2017
Q2 | $162K | Sell |
|
|||||
|
2017
Q1 | $264K | Sell |
|
|||||
|
2016
Q4 | $677K | Buy |
|
|||||
|
2016
Q3 | $607K | Sell |
|
|||||
|
2016
Q2 | $1.03M | Buy |
|
|||||
|
2016
Q1 | $257K | Sell |
|
|||||
|
2015
Q4 | $4.01M | Buy |
|
|||||
|
2015
Q3 | $756K | Sell |
|
|||||
|
2015
Q2 | $2.11M | Buy |
|
|||||
|
2015
Q1 | $2.23M | Buy |
|
|||||
|
2014
Q4 | $1.06M | Buy |
|